| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.21 | 0.06 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |